| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9B | $1.8B | $1.5B | $1.7B | $1.2B | $1.0B | $1.0B | $0.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.3B | $0.3B | $0.6B | $0.3B | $0.2B | $0.1B | $-0.0B |
| EPS (Basic) | $4.39 | $3.78 | $6.68 | $12.86 | $6.18 | $3.49 | $1.19 | $-0.46 |
| EPS (Diluted) | $4.37 | $3.74 | $6.61 | $12.74 | $6.11 | $3.46 | $1.18 | $-0.46 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.2B | $5.6B | $5.2B | $4.8B | $4.5B | $3.9B | $3.5B | $3.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | $4.4B | $4.1B | $3.8B | $3.6B | $3.3B | $2.8B | $2.6B | $2.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.8B | $1.5B | $1.4B | $1.2B | $1.2B | $1.1B | $1.0B | $0.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.6B | $0.5B | $0.3B | $0.4B | $0.3B | $0.3B | $0.2B |
| Investing Cash Flow | $-0.4B | $-0.3B | $-0.2B | $0.0B | $-0.3B | $-0.2B | $-0.2B | $-0.1B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.2B | $-0.2B | $-0.2B | $-0.4B | $-0.1B | $-0.1B | $-0.1B | $-0.1B |